Value based assessment of drugs

Value based assessment of drugs In 2010, the Government proposed moving towards a broader value-based system for assessing and pricing branded drugs. Such an approach aims to ensure that the price the NHS pays for a medicine better reflects its benefits. This briefing outlines recent proposals to change the current assessment methods.The Parliamentary Office of Science and Technology